Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice Y Chou

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Blood|April 19, 2008
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type IbSo Youn Kim, Hyun Sik Jun, Paul A Mead, et al.
FEBS Letters|July 31, 2007
Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type IaSo Youn Kim, Li-Yuan Chen, Wai Han Yiu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2008
The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and IcShih-Yin Chen, Chi-Jiunn Pan, Krishnamachary Nandigama, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 10, 2025
The Wnt/β-catenin signaling pathway mediates renal fibrosis in glycogen storage disease type Ib nephropathyKunal Pratap, Cheol Lee, Lisa Zhang, et al.
Molecular Genetics and Metabolism|October 16, 2025
Novel murine model provides insights into early-onset of kidney disease in glycogen storage disease type IbKunal Pratap, Cheol Lee, Lisa Zhang, et al.
Human Molecular Genetics|March 24, 2017
Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapyGoo-Young Kim, Joon Hyun Kwon, Jun-Ho Cho, et al.
Biochemical and Biophysical Research Communications|May 21, 2020
Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type IaLisa Zhang, Cheol Lee, Irina Arnaoutova, et al.
Journal of Hepatology|April 21, 2009
Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib miceWai Han Yiu, Chi-Jiunn Pan, Paul A Mead, et al.
Plos One|September 28, 2011
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiportersChi-Jiunn Pan, Shih-Yin Chen, Hyun Sik Jun, et al.
Journal of Inherited Metabolic Disease|July 19, 2023
CRISPR/Cas9-based double-strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type-IaAnanya Samanta, Nelson George, Irina Arnaoutova, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Blood|April 19, 2008
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type IbSo Youn Kim, Hyun Sik Jun, Paul A Mead, et al.
FEBS Letters|July 31, 2007
Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type IaSo Youn Kim, Li-Yuan Chen, Wai Han Yiu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 14, 2008
The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and IcShih-Yin Chen, Chi-Jiunn Pan, Krishnamachary Nandigama, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 10, 2025
The Wnt/β-catenin signaling pathway mediates renal fibrosis in glycogen storage disease type Ib nephropathyKunal Pratap, Cheol Lee, Lisa Zhang, et al.
Molecular Genetics and Metabolism|October 16, 2025
Novel murine model provides insights into early-onset of kidney disease in glycogen storage disease type IbKunal Pratap, Cheol Lee, Lisa Zhang, et al.
Human Molecular Genetics|March 24, 2017
Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapyGoo-Young Kim, Joon Hyun Kwon, Jun-Ho Cho, et al.
Biochemical and Biophysical Research Communications|May 21, 2020
Gene therapy using a novel G6PC-S298C variant enhances the long-term efficacy for treating glycogen storage disease type IaLisa Zhang, Cheol Lee, Irina Arnaoutova, et al.
Journal of Hepatology|April 21, 2009
Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib miceWai Han Yiu, Chi-Jiunn Pan, Paul A Mead, et al.
Plos One|September 28, 2011
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiportersChi-Jiunn Pan, Shih-Yin Chen, Hyun Sik Jun, et al.
Journal of Inherited Metabolic Disease|July 19, 2023
CRISPR/Cas9-based double-strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type-IaAnanya Samanta, Nelson George, Irina Arnaoutova, et al.
Pageof 6